VistaGen Therapeutics Inc. (VTGN)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMEX $
0. 23
-0.01
-4.1667%
$
8.07M Market Cap
- P/E Ratio
- Div Yield
701,500 Volume
-1.6 Eps
$ 0.24
Previous Close 
Want to track VTGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
VistaGen Therapeutics Inc. (VTGN) Statistics
Valuation metrics
Market Cap 8.07M
Enterprise value -22.23M
Trailing P/E (ttm) -0.12
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 5.91
Price/Book (mrq) 0.25
Enterprise Value/Revenue -17.51
Enterprise Value/EBITDA 0.32
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 685.84K
Average volume (90 days) 1.08M
Price summary
52-Week low 0.2
52-Week high 5.14
Beta -
50-Day moving average 0.57
200-Day moving average 0.61
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 7 Jun 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -54.87%
Operating margin -56.79%
Operational effectiveness
Return on assets -1.43%
Return on equity -1.33%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.19
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 3.67%
Book value per share (mrq) 0.93
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
